FDA approves blood test to detect colon cancer for those at ‘average risk’
The U.S. Food and Drug Administration on Monday morning approved a blood test to screen for colorectal cancer in certain individuals. The blood test, known as Shield and manufactured by Guardant Health, is already commercially available, but FDA approval will help broaden availability and insurance coverage. The test was approved for people aged 45 and … Read more